Information for Health Professionals
ASCIA develops Clinical Updates, Action/Treatment Plans, Guides, Checklists, Position Papers/Statements, Guidelines and e-training courses for health professionals.
Quick links for this page
COVID-19 | Allergic Rhinitis | Anaphylaxis | Drug Allergy | Food Allergy | Immunodeficiency | Immunisation
Allergen Immunotherapy | Allergy Prevention and Infant Feeding | Insect Allergy | Latex Allergy
Skin | Tests | External Documents
Allergen Immunotherapy | Allergy Prevention and Infant Feeding | Insect Allergy | Latex Allergy
Skin | Tests | External Documents
COVID-19
- ASCIA Position Statement - Specific Treatments for COVID-19 New April 2020
- ASCIA Position Statement - Immunoglobulin Therapies for COVID-19 New April 2020
- ASCIA Webinar - Part 1: HAE. Part 2: COVID-19 New April 2020
Allergic Rhinitis
- ASCIA Clinical Update - Allergic Rhinitis
- ASCIA Treatment Plan - Allergic Rhinitis
- ASCIA Allergic Rhinitis e-training for health professionals
- ASCIA Allergic Rhinitis e-training for pharmacists
- Australian Airborne Pollen and Spore Monitoring Network Interim Standard and Protocols
Allergy Prevention and Infant Feeding
- Overview - Infant feeding and allergy prevention
- ASCIA Clinical Update Infant Feeding and Allergy Prevention
- ASCIA Guidelines - Infant feeding and allergy prevention
- ASCIA Guide: Stepwise management of eczema (atopic dermatitis) management
- ASCIA Information on how to introduce solid foods to babies for allergy prevention
- ASCIA Guide for introduction of peanut to infants with severe eczema and/or food allergy
- ASCIA References: Allergy Prevention
Anaphylaxis
- ASCIA Guidelines - Acute management of anaphylaxis Updated July 2020
- ASCIA Guidelines - Acute management of anaphylaxis in pregnancy New April 2020
- ASCIA Guidelines - Adrenaline (epinephrine) autoinjector prescription Updated 2020
- ASCIA Guidelines - Prevention of anaphylaxis in schools, pre-schools and childcare: 2015 update
- ASCIA Anaphylaxis Resources Overview
- ASCIA Checklists - Anaphylaxis New and updated 2020
- ASCIA Event record for allergic reactions Updated 2020
- ASCIA Checklist - Transitioning patients from paediatric to adult services Updated 2020
- ASCIA Checklist - Travel for people with allergy, asthma and anaphylaxis Updated 2020
- ASCIA Anaphylaxis e-training for health professionals Updated 2020
- ASCIA Anaphylaxis e-training for pharmacists Updated 2020
Drug Allergy
- ASCIA Clinical Update - Antibiotic Allergy
- ASCIA Consensus Statement - Penicillin Allergy (available to Members only)
- ASCIA Drug allergy pre-clinic information template (available to Members only)
- ASCIA Penicillin Allergy Guide for health professionals
- ASCIA Penicillin Allergy etraining for health professionals
(https://etraininghp.ascia.org.au/penicillin-allergy)
Food Allergy
- ASCIA Guide for Milk Substitutes in Cow’s Milk Allergy New June 2020
- ASCIA Dietary avoidance information sheets
- ASCIA Information HP - Lupin Allergy
- ASCIA Food Allergy e-training for health professionals
- ASCIA Food Allergy e-training for pharmacists
- ASCIA Food Allergen Challenge Protocols (available to Members only)
Immunodeficiency
- Immunodeficiency Overview
- ASCIA Webinar - Part 1: HAE. Part 2: COVID-19 New April 2020
- ASCIA Position Paper and Management Plan - Hereditary Angioedema (HAE)
- ASCIA Clinical Update - Primary Immunodeficiencies (PID)
- ASCIA Position Statement - Subcutaneous Immunoglobulin (SCIg)
- ASCIA Guide – Setting up a Subcutaneous Immunoglobulin (SCIg) program in a hospital
- ASCIA Guidelines for Diagnosis and Management of Severe Combined Immunodeficiency (SCID) in Australia and New Zealand: A TAPID Consensus Guideline
- ASCIA Guidelines for standardised IVIg infusion rates for IRT
- ASCIA SCIg Treatment Plan
- ASCIA Transfer Care Plan for patients on IRT (immunoglobulin replacement therapy)
- ASCIA Travel Plan for patients on SCIg (subcutaneous immunoglobulin) therapy
- ASCIA ID Register How to access information (available to Members Only)
Immunisation
Insect Allergy
- ASCIA Guide - Venom Immunotherapy
- ASCIA Venom and Aeroallergen Immunotherapy templates (available to Members only)
- ASCIA Position Statement - Jack Jumper Ant Venom Immunotherapy
- ASCIA Information for HP - Jack Jumper Ant Allergy - a uniquely Australian problem
Latex Allergy
Skin
- ASCIA Action Plan for Eczema
- ASCIA Guide: Stepwise management of eczema (atopic dermatitis) management
- ASCIA Paediatric atopic dermatitis (eczema) e-training for health professionals
- ASCIA Guidelines: Chronic Spontaneous Urticaria (CSU)
Tests
- ASCIA Food Allergen Challenge Protocols (available to Members only)
- ASCIA Position Statement - Unorthodox Techniques for the Diagnosis and Treatment of Allergy, Asthma and Immune Disorders
- Allergy treatment declared misleading
- Vega Testing in the Diagnosis of Allergic Conditions
- ASCIA Manual - Skin Prick Testing for Allergy Diagnosis
- ASCIA Guidelines - Anti-Intrinsic Factor Antibody Testing
- ASCIA Guidelines - Uncertainty of Measurement
- Laboratory Tests in the Diagnosis of Allergic Diseases
- Unorthodox Testing and Treatment for Allergic Disorders
External Documents
- Australian Airborne Pollen and Spore Monitoring Network Interim Standard and Protocols
- Australian & New Zealand Anaesthetic Allergy Group (ANZAAG) - anaphylaxis management guidelines
- Australian Prescriber Anaphylaxis Wall Chart
- Australian Academy of Science - The science of immunisation
- APIIEG Consensus Recommendations for the Use of Immunoglobulin Replacement Therapy in Immune Deficiency
- Guidelines for the Use of Infant Formulas to Treat Cows Milk Protein Allergy: an Australian Consensus Panel Opinion
- European Academy of Allergology and Clinical Immunology (EAACI) Testing for IgG4 against Foods is Not Recommended as a Diagnostic Tool
For information about how ASCIA information is developed go to: www.allergy.org.au/about-ascia/website-information
Content updated June 2020
